|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.288 SEK | -6.12% |
|
-7.87% | -34.62% |
| 07-08 | Irlab board member James Gamgort buys shares for just under SEK 0.3m | FW |
| 06-30 | IRLAB Therapeutics AB Approves Election of Janne Backman as Vice Chairperson of the Board of Directors | CI |
EPS & Dividend: IRLAB Therapeutics AB
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -1.922 | 1 | -2.188 | -3.429 | -1.603 | -1.642 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 42.000 | 44.000 | 38.300 | 7.500 | 10.750 | 1.970 |
| Nbr of stocks (in thousands) | 51,748 | 51,748 | 51,868 | 51,868 | 51,868 | 84,938 |
| Announcement Date | 4/15/21 | 4/8/22 | 4/29/24 | 4/29/24 | 4/25/25 | 4/29/26 |
1SEK in Million2SEK
Estimates
Past dividends: IRLAB Therapeutics AB
| 2026-06-08 | Ex-dividend date - 0.97854 SEK | 00:00 |
Upcoming Events: IRLAB Therapeutics AB
| 2026-08-26 | Earnings release | Q2 2026 | |
| 2026-11-13 | Earnings release | Q3 2026 | |
| 2027-02-11 | Earnings release | Annual 2026 | Day |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 0.57% | 0.64% | 35.04x | 21.39x | 12.53x | |
| 2.12% | 2.22% | 27.19x | 6.81x | 6.2x | |
| 2.7% | 2.84% | 33.15x | 12667.5x | 7.52x | |
| 3% | 3.07% | 17.85x | 6.61x | 4.43x | |
| 2.84% | 2.93% | 21.66x | 6.24x | 5.55x | |
| 1.97% | 2.08% | 21.16x | 4.96x | 4.46x | |
| 3.44% | 3.34% | 14.44x | 6.38x | 5.41x | |
| 2.75% | 2.91% | 24.02x | 18.48x | 6.35x | |
| 2.42% | 2.5% | -48.37x | 8.47x | 5.78x | |
| Average | 2.42% | 2.5% | 16.24x | 1,416.31x | 6.47x | |
| Weighted average by Cap. | 2% | 2.08% | 24.01x | 1,603.91x | 7.82x |
Annual Profit -
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
